A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment.
| Author | |
|---|---|
| Abstract | :
Doxylamine tablets are approved as an over-the-counter sleep aid. We developed a doxylamine succinate intranasal metered-dose delivery system with the expectation of a more rapid onset of action with reduced side-effect potential compared with the oral tablet. |
| Year of Publication | :
2018
|
| Journal | :
Drugs in R&D
|
| Volume | :
18
|
| Issue | :
2
|
| Number of Pages | :
129-136
|
| ISSN Number | :
1174-5886
|
| URL | :
https://dx.doi.org/10.1007/s40268-018-0232-1
|
| DOI | :
10.1007/s40268-018-0232-1
|
| Short Title | :
Drugs R D
|
| Download citation |